$20.66
-3.1%Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
Chief Audit & Compliance Officer
Chief Executive Officer & Director
Compensation
$1,329,353
Chief Operating Officer
Chief People Officer
Executive Vice President & Chief Technology Officer
Executive Vice President of Medical Groups
Executive Vice President, Chief Financial Officer & Principal Accounting Officer
Compensation
$757,113
Executive Vice President, General Counsel, Chief Legal Officer & Corporate Secretary
Compensation
$650,474
Senior Vice President & Chief Growth Officer
Senior Vice President of Investor Relations & Corporate Communications
During the last 12 months, insiders have sold $9.12M worth of PRVA shares, with no buying activity reported.
0
0.00
320.9K
7.24M
-7.2M
-$7.24M
0
0.00
74.9K
1.87M
-1.9M
-$1.87M
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
No buying activity
Mehrotra Parth
Director, Officer: Chief Executive Officer
$5.97M
Mountcastle David
Officer: Evp & Chief Financial Officer
$1.75M
Morris Matthew Shawn
Director
$1.40M
Strong bearish signal with $9.12M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
3 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
PRVA - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 02, 2026 | May 20, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 04, 2025 | May 21, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 04, 2024 | May 22, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 06, 2023 | April 06, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 11, 2022 | May 11, 2022 | 2022 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.